← Back to Clinical Trials
Recruiting NCT06869967

NCT06869967 Evaluation of Postoperative Pain Control in Ear Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06869967
Status Recruiting
Phase
Sponsor Kocaeli University
Condition Post Operative Pain
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-10-20
Primary Completion 2026-11-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Auricularis Magnus Nerve BlockControl Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2025-10-20 with a primary completion date of 2026-11-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Middle ear surgery is the most popular procedure in ear, nose and throat surgery. Increased sympathetic stimulation after surgery can activate the sympathetic system, causing hypertension and increased heart rate. As a result of these clinical conditions, hemorrhage can occur, which can impair the quality of the surgical field, which is undesirable in middle ear surgery.Clinical studies should be conducted with auricularis magnus nerve block applied in the perioperative period in middle ear surgery and postoperative pain scores.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing CWD and Mastodectom * Patients undergoing elective surgery * ASA (American Society of Anesthesiologists) physical status classification I-II * Patients over 18 years of age Exclusion Criteria: * Anticoagulant use * Allergy to the drugs to be used * ASA (American Society of Anesthesiologists) physical status classification IV-V * Presence of infection in the area where the block will be applied * Patient's refusal to accept the block application or inability to cooperate with the patient

Contact & Investigator

Central Contact

Nur Nazire YUCAL, MD

✉ n_395@hotmail.com

📞 05443898086

Frequently Asked Questions

Who can join the NCT06869967 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06869967 currently recruiting?

Yes, NCT06869967 is actively recruiting participants. Contact the research team at n_395@hotmail.com for enrollment information.

Where is the NCT06869967 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06869967 clinical trial?

NCT06869967 is sponsored by Kocaeli University. The trial plans to enroll 56 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology